| Similar Articles |
|---|
 |
American Family Physician
February 15, 2005
Mark H. Ebell |
Evidence-Based Initiation of Warfarin (Coumadin) Many physicians continue to use clinical judgment alone as the basis for initiating and adjusting warfarin dosages in patients who require oral anticoagulation.   |
Nurse Practitioner
March 2009
Patricia Weyland |
Warfarin Therapy Management :Tap in to New Ways to Slow the Clot Patients on warfarin require close monitoring in order to decrease their risk of clotting, while also decreasing their risk of bleeding. |
American Family Physician
June 15, 2005
Mark H. Ebell |
Decision-Making Tool for Treating Patients with Nonvalvular Atrial Fibrillation What is the risk of stroke in a patient with nonvalvular atrial fibrillation, and should that patient be given warfarin (Coumadin) or aspirin? |
American Family Physician
June 15, 2004
Ramzi & Leeper |
DVT and Pulmonary Embolism: Part II. Treatment and Prevention Evaluation for thrombophilias and other secondary causes of venous thromboembolic disease, presents an evidence-based approach to the treatment of DVT and PE, and reviews current recommendations for prevention of venous thromboembolism. |
Nursing
February 2012
Pezzotti & Freuler |
Using anticoagulants to steer clear of clots This article will review coagulation and provide important information about several commonly used anticoagulants and their reversal agents. |
American Family Physician
July 15, 2002
Dana E. King |
Acute Management of Atrial Fibrillation: Part II. Prevention of Thromboembolic Complications Family physicians should be familiar with the acute management of atrial fibrillation and the initiation of chronic therapy for this common arrhythmia. Part II of this two-part article focuses on the prevention of thromboembolic complications using anticoagulation. |
American Family Physician
March 15, 2005
Paul Gross |
Diary From a Week in Pactice A family practitioner comes up with an easy diagnosis... Is bothered by the management of warfarin... Is touched by patient correspondence... etc. |
American Family Physician
December 15, 2005
Kathy Soch |
Diary From a Week in Pactice A family physician congratulates a 9-year-old boy on his state achievement test in reading... Talks to a 78-years-old Hurricane Katrina victim about riding an airplane... Tweaks a patient's warfarin dosage... etc. |
Managed Care
May 2000
Mark G. Weiner, M.D., and Eric Pifer, M.D. |
Computerized Decision Support and the Quality of Care The notion of quality of care in medicine is not new, but it is becoming increasingly important as the competitive health care market demands objective measures to compare physicians, hospitals, and managed care organizations.... |
American Family Physician
October 15, 2005
Kathy Soch |
Diary From a Week in Pactice This family practitioner checks in on a patient with severe expressive aphasia... Sees a chronic pessimist... Recommends documenting a resident's pre-operative clearance for a patient... etc. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
American Journal of Nursing
October 2009 |
Pharmacogenomics: Personalizing Drug Therapy Pharmacogenomics is a rapidly growing field of research into the ways in which genetic variation affects drug response. |
Nurse Practitioner
September 2010
Sarah E. Gay |
An inside view of Venous Thromboembolism As the U.S. population ages, the medical and economic impact of VTE is expected to increase. The nurse practitioner plays a key role in providing prevention and intervention. |
American Family Physician
October 15, 2000 |
Diary from a Week in Practice Presenting various aspects of the life of a family physician to a first grade class... Co-sleeping with children may be helpful... 38 herbal treatments have the potential to interact with warfarin... ASW joins the practice... Enjoying a livestock fair... |
The Motley Fool
June 11, 2010
Brian Orelli |
Pfizer and Bristol Coagulate Against Clots Let's see how apixaban does against warfarin before we break out the "blockbuster" stamp. |
The Motley Fool
November 15, 2010
Brian Orelli |
A Mega-Blockbuster Showdown Boehringer Ingelheim's Pradaxa was recently approved to treat patients with an erratic heartbeat, and Bayer and Johnson & Johnson have a second compound, Xarelto, that isn't far behind. |
The Motley Fool
August 17, 2007
Brian Orelli |
FDA's Rigor May Boost Sales The FDA is updating labeling of certain blood-thinning drugs, indicating that patients may want to obtain a genetic test prior to taking the medication. This move may lead to increased testing, and hopefully increased prescriptions. |
Nursing
March 2011
Mink & Miller |
Stroke, Part 2: Respond aggressively to hemorrhagic stroke Patients may arrive at the hospital any time from minutes to days after a hemorrhagic stroke, and nurses need to be prepared for the unique challenges associated with their care. |
The Motley Fool
August 24, 2011
Alexander Crawford |
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful How big could this market be? |
The Motley Fool
June 23, 2011
Brian Orelli |
In Addition, Our Drug Actually Rocks Pfizer and Bristol get good data on Eliquis. |
